MARKET WIRE NEWS

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2024 Earnings Call Transcript

Source: SeekingAlpha

2025-02-01 08:03:01 ET

Chugai Pharmaceutical Co., Ltd. (CHGCF)

Q4 2024 Earnings Conference Call

January 30, 2025 3:30 AM ET

Company Participants

Kae Miyata - Head of Corporate Communications Department

Osamu Okuda - Representative Director, President, and Chief Executive Officer

Michiaki Tanaka - Head, R&D Portfolio Management Department, Project and Lifecycle Management Unit

Iwaaki Taniguchi - Director, Executive Vice President, and Chief Financial Officer

Takao Suzuki - Associate Vice President, Head of the Digital Transformation Unit

Conference Call Participants

Kazuaki Hashiguchi - Daiwa Securities

Fumiyoshi Sakai - UBS Securities

Seiji Wakao - JPMorgan Securities

Hidemaru Yamaguchi - Citigroup Global Markets

Stephen Barker - Jefferies

Tony Ren - Macquarie Capital Securities

Shinichiro Muraoka - Morgan Stanley MUFG Securities

Miki Sogi - AllianceBernstein Japan

Presentation

Kae Miyata

Ladies and gentlemen, thank you for attending the conference on FY 2024 December financial results for Chugai Pharmaceutical. I am acting as a master of ceremony for today. My name is Miyata from the IR Department. We are holding this session in a hybrid manner.

The agenda for today's presentation are shown on the presentation material page three as well as the screen in the venue. However, for those who are participating through Zoom webinar, you will be able to listen to the simultaneous translation [Technical Difficulty] the language of your choice by clicking the button at the bottom of your screen. For those who wish to listen to Japanese, please select Japanese. For those who wish to listen to English, please select English. After selecting your preferred language, please click on mute original audio.

At the beginning of each session, we are going to pause for a while for those who [Technical Difficulty] to take a photo of the screen. We are going to take questions at the very end of the presentation. We allocate about 30 minutes for the Q&A session. Audio is muted during the presentation session.

Now, Okuda will take you through a summary of the year 2024 and the outlook into 2025. We are going to pause for a while before the presentation of Okuda. So for those who wish to take a screen capture, please do so.

Osamu Okuda

Now I'd like to start the presentation. I am Okuda, the President. I'll explain the summary of 2024 and the forecast for 2025....

Read the full article on Seeking Alpha

For further details see:

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2024 Earnings Call Transcript
Chugai Pharmaceutical

NASDAQ: CHGCF

CHGCF Trading

-0.72% G/L:

$59.755 Last:

1,694 Volume:

$60.2825 Open:

mwn-link-x Ad 300

CHGCF Latest News

CHGCF Stock Data

$102,957,945,846
1,644,317,724
N/A
N/A
Pharmaceuticals
Healthcare
JP
Chuo-Ku

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App